Connect Biopharma: Qiming Corporate GP V reports 2.9% stake
The reported ownership percentages use 62,974,309 ordinary shares outstanding as of July 31, 2026, and the notes describe general-partner relationships among reporting entities.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Connect Biopharma Holdings Ltd (CNTB) is the issuer for which seven Qiming entities report beneficial ownership in an amended ownership report. Reported amounts are 54,826 ordinary shares (0.1%) for Qiming Managing Directors Fund V, L.P.; 1,766,600 (2.8%) for each of Qiming Venture Partners V, L.P. and Qiming GP V, L.P.; 1,821,426 (2.9%) for Qiming Corporate GP V, Ltd.; 935,064 (1.5%) for Qiming GP VII, LLC; 926,527 (1.5%) for Qiming Venture Partners VII, L.P.; and 8,537 (0.0%) for Qiming VII Strategic Investors Fund, L.P.
The report’s notes describe general-partner relationships among the reporting entities. The stated percentages use 62,974,309 ordinary shares outstanding as of July 31, 2026.
Key Figures
Qiming Managing Directors Fund V beneficial ownership:54,826 ordinary shares; 0.1%Qiming Venture Partners V beneficial ownership:1,766,600 ordinary shares; 2.8%Qiming Corporate GP V beneficial ownership:1,821,426 ordinary shares; 2.9%+5 more
8 metrics
Qiming Managing Directors Fund V beneficial ownership54,826 ordinary shares; 0.1%Reported amount and percentage of class
Qiming Venture Partners V beneficial ownership1,766,600 ordinary shares; 2.8%Reported amount and percentage of class
Qiming Corporate GP V beneficial ownership1,821,426 ordinary shares; 2.9%Reported amount and percentage of class
Qiming GP V beneficial ownership1,766,600 ordinary shares; 2.8%Reported amount and percentage of class
Qiming GP VII beneficial ownership935,064 ordinary shares; 1.5%Reported amount and percentage of class
Qiming Venture Partners VII beneficial ownership926,527 ordinary shares; 1.5%Reported amount and percentage of class
Qiming VII Strategic Investors Fund beneficial ownership8,537 ordinary shares; 0.0%Reported amount and percentage of class
Ordinary shares outstanding62,974,309 ordinary sharesAs of July 31, 2026; basis for reported percentages
Key Terms
beneficially owned, Sole Voting Power, Shared Voting Power, Sole Dispositive Power
4 terms
beneficially ownedfinancial
"Amount beneficially owned"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Powerfinancial
"Sole Voting Power"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Shared Voting Powerfinancial
"Shared Voting Power"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Sole Dispositive Powerfinancial
"Sole Dispositive Power"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many CNTB ordinary shares does Qiming Corporate GP V report?
Qiming Corporate GP V, Ltd. reports beneficial ownership of 1,821,426 ordinary shares, or 2.9% of the class.
What share count is used for CNTB ownership percentages?
The percentages are based on 62,974,309 ordinary shares issued and outstanding as of July 31, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Connect Biopharma Holdings Ltd
(Name of Issuer)
Ordinary shares, par value US$0.000174 per share
(Title of Class of Securities)
G23549101
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming Managing Directors Fund V, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
54,826.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
54,826.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
54,826.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.1 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming Venture Partners V, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
1,766,600.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
1,766,600.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,766,600.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.8 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming Corporate GP V, Ltd.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
1,821,426.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
1,821,426.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,821,426.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.9 %
12
Type of Reporting Person (See Instructions)
CO
Comment for Type of Reporting Person: Note to Rows (5) (7) and (9): As of the date of this Schedule 13G filing, Qiming Corporate GP V, Ltd. is the general partner of Qiming Managing Directors Fund V, L.P. ("QMD V") and Qiming GP V, L.P. ("QGP V"). QGP V is the general partner of Qiming Venture Partners V, L.P. ("QVP V"). QMD V and QVP V hold 54,826 ordinary shares and 1,766,600 ordinary shares, respectively.
Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming GP V, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
1,766,600.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
1,766,600.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,766,600.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.8 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming GP VII, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
935,064.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
935,064.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
935,064.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.5 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: Note to Rows (5) (7) and (9): As of the date of this Schedule 13G filing, Qiming GP VII, LLC is the general partner of Qiming Venture Partners VII, L.P. and Qiming VII Strategic Investors Fund, L.P., which hold 926,527 ordinary shares and 8,537 ordinary shares, respectively.
Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming Venture Partners VII, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
926,527.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
926,527.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
926,527.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.5 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
CUSIP Number(s):
G23549101
1
Names of Reporting Persons
Qiming VII Strategic Investors Fund, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
8,537.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
8,537.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,537.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: Note to Row (11): The percentage is calculated based upon an aggregate of 62,974,309 ordinary shares that were issued and outstanding as of July 31, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 12, 2026.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Connect Biopharma Holdings Ltd
(b)
Address of issuer's principal executive offices:
3580 Carmel Mountain Road, Suite 200, San Diego, CA, 92130.
Item 2.
(a)
Name of person filing:
Qiming Corporate GP V, Ltd.
Qiming Managing Directors Fund V, L.P.
Qiming GP V, L.P.
Qiming Venture Partners V, L.P.
Qiming GP VII, LLC
Qiming Venture Partners VII, L.P.
Qiming VII Strategic Investors Fund, L.P.
(b)
Address or principal business office or, if none, residence:
The registered address of each of the Reporting Persons is PO Box 309GT, Ugland House, South Church Street, George Town, Grand Cayman, KY1-1104, Cayman Islands.
(c)
Citizenship:
Cayman Islands
(d)
Title of class of securities:
Ordinary shares, par value US$0.000174 per share
(e)
CUSIP No.:
G23549101
Item 4.
Ownership
(a)
Amount beneficially owned:
The information set forth in Row (9) of the cover page for each of the Reporting Person is incorporated herein by reference.
(b)
Percent of class:
The information set forth in Row (11) of the cover page for each of the Reporting Person is incorporated herein by reference.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information set forth in Row (5) of the cover page for each of the Reporting Person is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information set forth in Row (6) of the cover page for each of the Reporting Person is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information set forth in Row (7) of the cover page for each of the Reporting Person is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information set forth in Row (8) of the cover page for each of the Reporting Person is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Qiming Managing Directors Fund V, L.P.
Signature:
/s/ Holan Lam
Name/Title:
Holan Lam/Authorized Signatory on behalf of Qiming Corporate GP V, Ltd., it's General Partner
Date:
11/03/2026
Qiming Venture Partners V, L.P.
Signature:
/s/ Holan Lam/
Name/Title:
Holan Lam/Authorized Signatory on behalf of Qiming Corporate GP V, Ltd., General Partner of Qiming GP V, L.P, it's General Partner
Date:
11/03/2026
Qiming Corporate GP V, Ltd.
Signature:
/s/ Holan Lam
Name/Title:
Holan Lam/Authorized Signatory
Date:
11/03/2026
Qiming GP V, L.P.
Signature:
/s/ Holan Lam
Name/Title:
Holan Lam/Authorized Signatory on behalf of Qiming Corporate GP V, Ltd., it's General Partner
Date:
11/03/2026
Qiming GP VII, LLC
Signature:
/s/ Holan Lam
Name/Title:
Holan Lam/Authorized Signatory
Date:
11/03/2026
Qiming Venture Partners VII, L.P.
Signature:
/s/ Holan Lam
Name/Title:
Holan Lam/Authorized Signatory on behalf of Qiming GP VII, LLC, it's General Partner
Date:
11/03/2026
Qiming VII Strategic Investors Fund, L.P.
Signature:
/s/ Holan Lam
Name/Title:
Holan Lam/Authorized Signatory on behalf of Qiming GP VII, LLC, it's General Partner
Date:
11/03/2026
Exhibit Information
Exhibit No. 99.1: Joint Filing Agreement, dated as of February 14, 2022 (incorporated by reference to Exhibit to the Reporting Persons' Schedule 13G filed with the SEC on February 14, 2022).
